nodes	percent_of_prediction	percent_of_DWPC	metapath
Clavulanate—Thrombocytopenia—Melphalan—breast cancer	0.00214	0.00214	CcSEcCtD
Clavulanate—Haemoglobin—Fluorouracil—breast cancer	0.00213	0.00213	CcSEcCtD
Clavulanate—Anaphylactic shock—Goserelin—breast cancer	0.00213	0.00213	CcSEcCtD
Clavulanate—Haemorrhage—Fluorouracil—breast cancer	0.00212	0.00212	CcSEcCtD
Clavulanate—Diarrhoea—Raloxifene—breast cancer	0.00212	0.00212	CcSEcCtD
Clavulanate—Diarrhoea—Idarubicin—breast cancer	0.00212	0.00212	CcSEcCtD
Clavulanate—Leukopenia—Vinorelbine—breast cancer	0.0021	0.0021	CcSEcCtD
Clavulanate—Thrombocytopenia—Goserelin—breast cancer	0.00209	0.00209	CcSEcCtD
Clavulanate—Vomiting—Letrozole—breast cancer	0.00207	0.00207	CcSEcCtD
Clavulanate—Vomiting—Anastrozole—breast cancer	0.00207	0.00207	CcSEcCtD
Clavulanate—Nausea—Ixabepilone—breast cancer	0.00206	0.00206	CcSEcCtD
Clavulanate—Rash—Anastrozole—breast cancer	0.00206	0.00206	CcSEcCtD
Clavulanate—Rash—Letrozole—breast cancer	0.00206	0.00206	CcSEcCtD
Clavulanate—Dermatitis—Anastrozole—breast cancer	0.00206	0.00206	CcSEcCtD
Clavulanate—Dermatitis—Letrozole—breast cancer	0.00206	0.00206	CcSEcCtD
Clavulanate—Erythema multiforme—Gemcitabine—breast cancer	0.00204	0.00204	CcSEcCtD
Clavulanate—Leukopenia—Thiotepa—breast cancer	0.002	0.002	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Paclitaxel—breast cancer	0.002	0.002	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Docetaxel—breast cancer	0.002	0.002	CcSEcCtD
Clavulanate—Urticaria—Chlorambucil—breast cancer	0.00199	0.00199	CcSEcCtD
Clavulanate—Vomiting—Raloxifene—breast cancer	0.00197	0.00197	CcSEcCtD
Clavulanate—Vomiting—Idarubicin—breast cancer	0.00197	0.00197	CcSEcCtD
Clavulanate—Pain—Vinblastine—breast cancer	0.00197	0.00197	CcSEcCtD
Clavulanate—Rash—Idarubicin—breast cancer	0.00195	0.00195	CcSEcCtD
Clavulanate—Rash—Raloxifene—breast cancer	0.00195	0.00195	CcSEcCtD
Clavulanate—Hypokalaemia—Capecitabine—breast cancer	0.00195	0.00195	CcSEcCtD
Clavulanate—Dermatitis—Raloxifene—breast cancer	0.00195	0.00195	CcSEcCtD
Clavulanate—Dermatitis—Idarubicin—breast cancer	0.00195	0.00195	CcSEcCtD
Clavulanate—Nausea—Anastrozole—breast cancer	0.00194	0.00194	CcSEcCtD
Clavulanate—Nausea—Letrozole—breast cancer	0.00194	0.00194	CcSEcCtD
Clavulanate—Convulsion—Thiotepa—breast cancer	0.00194	0.00194	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Capecitabine—breast cancer	0.00193	0.00193	CcSEcCtD
Clavulanate—Anaphylactic shock—Vinorelbine—breast cancer	0.00191	0.00191	CcSEcCtD
Clavulanate—Pain—Tamoxifen—breast cancer	0.00191	0.00191	CcSEcCtD
Clavulanate—Thrombocytopenia—Vinorelbine—breast cancer	0.00187	0.00187	CcSEcCtD
Clavulanate—Pain—Melphalan—breast cancer	0.00187	0.00187	CcSEcCtD
Clavulanate—Hypersensitivity—Chlorambucil—breast cancer	0.00185	0.00185	CcSEcCtD
Clavulanate—Thrombophlebitis—Methotrexate—breast cancer	0.00184	0.00184	CcSEcCtD
Clavulanate—Nausea—Raloxifene—breast cancer	0.00184	0.00184	CcSEcCtD
Clavulanate—Nausea—Idarubicin—breast cancer	0.00184	0.00184	CcSEcCtD
Clavulanate—Pain—Goserelin—breast cancer	0.00182	0.00182	CcSEcCtD
Clavulanate—Haemoglobin—Paclitaxel—breast cancer	0.00182	0.00182	CcSEcCtD
Clavulanate—Haemorrhage—Paclitaxel—breast cancer	0.00181	0.00181	CcSEcCtD
Clavulanate—Thrombocytopenia—Thiotepa—breast cancer	0.00179	0.00179	CcSEcCtD
Clavulanate—Pruritus—Chlorambucil—breast cancer	0.00177	0.00177	CcSEcCtD
Clavulanate—Urticaria—Tamoxifen—breast cancer	0.00177	0.00177	CcSEcCtD
Clavulanate—Urticaria—Melphalan—breast cancer	0.00174	0.00174	CcSEcCtD
Clavulanate—Leukopenia—Irinotecan—breast cancer	0.00173	0.00173	CcSEcCtD
Clavulanate—Leukopenia—Mitoxantrone—breast cancer	0.00173	0.00173	CcSEcCtD
Clavulanate—Thrombophlebitis—Epirubicin—breast cancer	0.00173	0.00173	CcSEcCtD
Clavulanate—Diarrhoea—Chlorambucil—breast cancer	0.00172	0.00172	CcSEcCtD
Clavulanate—Erythema multiforme—Paclitaxel—breast cancer	0.00171	0.00171	CcSEcCtD
Clavulanate—Urticaria—Goserelin—breast cancer	0.00169	0.00169	CcSEcCtD
Clavulanate—Hypersensitivity—Vinblastine—breast cancer	0.00169	0.00169	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Docetaxel—breast cancer	0.00169	0.00169	CcSEcCtD
Clavulanate—Leukopenia—Gemcitabine—breast cancer	0.00168	0.00168	CcSEcCtD
Clavulanate—Convulsion—Mitoxantrone—breast cancer	0.00167	0.00167	CcSEcCtD
Clavulanate—Leukopenia—Fluorouracil—breast cancer	0.00165	0.00165	CcSEcCtD
Clavulanate—Hypersensitivity—Tamoxifen—breast cancer	0.00165	0.00165	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Capecitabine—breast cancer	0.00164	0.00164	CcSEcCtD
Clavulanate—Pain—Vinorelbine—breast cancer	0.00163	0.00163	CcSEcCtD
Clavulanate—Hypersensitivity—Melphalan—breast cancer	0.00161	0.00161	CcSEcCtD
Clavulanate—Convulsion—Fluorouracil—breast cancer	0.0016	0.0016	CcSEcCtD
Clavulanate—Thrombophlebitis—Doxorubicin—breast cancer	0.0016	0.0016	CcSEcCtD
Clavulanate—Vomiting—Chlorambucil—breast cancer	0.00159	0.00159	CcSEcCtD
Clavulanate—Pruritus—Tamoxifen—breast cancer	0.00158	0.00158	CcSEcCtD
Clavulanate—Anaphylactic shock—Irinotecan—breast cancer	0.00158	0.00158	CcSEcCtD
Clavulanate—Anaphylactic shock—Mitoxantrone—breast cancer	0.00158	0.00158	CcSEcCtD
Clavulanate—Diarrhoea—Vinblastine—breast cancer	0.00157	0.00157	CcSEcCtD
Clavulanate—Hypersensitivity—Goserelin—breast cancer	0.00157	0.00157	CcSEcCtD
Clavulanate—Pain—Thiotepa—breast cancer	0.00156	0.00156	CcSEcCtD
Clavulanate—Pruritus—Melphalan—breast cancer	0.00155	0.00155	CcSEcCtD
Clavulanate—Thrombocytopenia—Irinotecan—breast cancer	0.00154	0.00154	CcSEcCtD
Clavulanate—Thrombocytopenia—Mitoxantrone—breast cancer	0.00154	0.00154	CcSEcCtD
Clavulanate—Haemoglobin—Docetaxel—breast cancer	0.00154	0.00154	CcSEcCtD
Clavulanate—Anaphylactic shock—Gemcitabine—breast cancer	0.00153	0.00153	CcSEcCtD
Clavulanate—Hepatitis—Docetaxel—breast cancer	0.00153	0.00153	CcSEcCtD
Clavulanate—Haemorrhage—Docetaxel—breast cancer	0.00153	0.00153	CcSEcCtD
Clavulanate—Diarrhoea—Tamoxifen—breast cancer	0.00153	0.00153	CcSEcCtD
Clavulanate—Urticaria—Vinorelbine—breast cancer	0.00152	0.00152	CcSEcCtD
Clavulanate—Pruritus—Goserelin—breast cancer	0.00151	0.00151	CcSEcCtD
Clavulanate—Anaphylactic shock—Fluorouracil—breast cancer	0.00151	0.00151	CcSEcCtD
Clavulanate—Thrombocytopenia—Gemcitabine—breast cancer	0.0015	0.0015	CcSEcCtD
Clavulanate—Diarrhoea—Melphalan—breast cancer	0.0015	0.0015	CcSEcCtD
Clavulanate—Haemoglobin—Capecitabine—breast cancer	0.00149	0.00149	CcSEcCtD
Clavulanate—Nausea—Chlorambucil—breast cancer	0.00149	0.00149	CcSEcCtD
Clavulanate—Haemorrhage—Capecitabine—breast cancer	0.00148	0.00148	CcSEcCtD
Clavulanate—Hepatitis—Capecitabine—breast cancer	0.00148	0.00148	CcSEcCtD
Clavulanate—Thrombocytopenia—Fluorouracil—breast cancer	0.00148	0.00148	CcSEcCtD
Clavulanate—Vomiting—Vinblastine—breast cancer	0.00146	0.00146	CcSEcCtD
Clavulanate—Diarrhoea—Goserelin—breast cancer	0.00146	0.00146	CcSEcCtD
Clavulanate—Erythema multiforme—Docetaxel—breast cancer	0.00145	0.00145	CcSEcCtD
Clavulanate—Urticaria—Thiotepa—breast cancer	0.00145	0.00145	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Methotrexate—breast cancer	0.00144	0.00144	CcSEcCtD
Clavulanate—Vomiting—Tamoxifen—breast cancer	0.00142	0.00142	CcSEcCtD
Clavulanate—Leukopenia—Paclitaxel—breast cancer	0.00141	0.00141	CcSEcCtD
Clavulanate—Rash—Tamoxifen—breast cancer	0.00141	0.00141	CcSEcCtD
Clavulanate—Hypersensitivity—Vinorelbine—breast cancer	0.00141	0.00141	CcSEcCtD
Clavulanate—Dermatitis—Tamoxifen—breast cancer	0.00141	0.00141	CcSEcCtD
Clavulanate—Erythema multiforme—Capecitabine—breast cancer	0.0014	0.0014	CcSEcCtD
Clavulanate—Vomiting—Melphalan—breast cancer	0.00139	0.00139	CcSEcCtD
Clavulanate—Rash—Melphalan—breast cancer	0.00138	0.00138	CcSEcCtD
Clavulanate—Dermatitis—Melphalan—breast cancer	0.00138	0.00138	CcSEcCtD
Clavulanate—Eosinophilia—Methotrexate—breast cancer	0.00137	0.00137	CcSEcCtD
Clavulanate—Nausea—Vinblastine—breast cancer	0.00137	0.00137	CcSEcCtD
Clavulanate—Convulsion—Paclitaxel—breast cancer	0.00136	0.00136	CcSEcCtD
Clavulanate—Hypokalaemia—Epirubicin—breast cancer	0.00136	0.00136	CcSEcCtD
Clavulanate—Vomiting—Goserelin—breast cancer	0.00136	0.00136	CcSEcCtD
Clavulanate—Pruritus—Vinorelbine—breast cancer	0.00135	0.00135	CcSEcCtD
Clavulanate—Pain—Irinotecan—breast cancer	0.00135	0.00135	CcSEcCtD
Clavulanate—Pain—Mitoxantrone—breast cancer	0.00135	0.00135	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Epirubicin—breast cancer	0.00135	0.00135	CcSEcCtD
Clavulanate—Rash—Goserelin—breast cancer	0.00134	0.00134	CcSEcCtD
Clavulanate—Hypersensitivity—Thiotepa—breast cancer	0.00134	0.00134	CcSEcCtD
Clavulanate—Dermatitis—Goserelin—breast cancer	0.00134	0.00134	CcSEcCtD
Clavulanate—Nausea—Tamoxifen—breast cancer	0.00133	0.00133	CcSEcCtD
Clavulanate—Pain—Gemcitabine—breast cancer	0.00131	0.00131	CcSEcCtD
Clavulanate—Diarrhoea—Vinorelbine—breast cancer	0.00131	0.00131	CcSEcCtD
Clavulanate—Nausea—Melphalan—breast cancer	0.0013	0.0013	CcSEcCtD
Clavulanate—Pruritus—Thiotepa—breast cancer	0.00129	0.00129	CcSEcCtD
Clavulanate—Pain—Fluorouracil—breast cancer	0.00129	0.00129	CcSEcCtD
Clavulanate—Anaphylactic shock—Paclitaxel—breast cancer	0.00128	0.00128	CcSEcCtD
Clavulanate—Eosinophilia—Epirubicin—breast cancer	0.00128	0.00128	CcSEcCtD
Clavulanate—Nausea—Goserelin—breast cancer	0.00127	0.00127	CcSEcCtD
Clavulanate—Hypokalaemia—Doxorubicin—breast cancer	0.00126	0.00126	CcSEcCtD
Clavulanate—Thrombocytopenia—Paclitaxel—breast cancer	0.00126	0.00126	CcSEcCtD
Clavulanate—Urticaria—Mitoxantrone—breast cancer	0.00125	0.00125	CcSEcCtD
Clavulanate—Diarrhoea—Thiotepa—breast cancer	0.00125	0.00125	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Doxorubicin—breast cancer	0.00125	0.00125	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Methotrexate—breast cancer	0.00122	0.00122	CcSEcCtD
Clavulanate—Vomiting—Vinorelbine—breast cancer	0.00121	0.00121	CcSEcCtD
Clavulanate—Rash—Vinorelbine—breast cancer	0.0012	0.0012	CcSEcCtD
Clavulanate—Dermatitis—Vinorelbine—breast cancer	0.0012	0.0012	CcSEcCtD
Clavulanate—Urticaria—Fluorouracil—breast cancer	0.0012	0.0012	CcSEcCtD
Clavulanate—Leukopenia—Docetaxel—breast cancer	0.00119	0.00119	CcSEcCtD
Clavulanate—Eosinophilia—Doxorubicin—breast cancer	0.00118	0.00118	CcSEcCtD
Clavulanate—Hypersensitivity—Mitoxantrone—breast cancer	0.00116	0.00116	CcSEcCtD
Clavulanate—Hypersensitivity—Irinotecan—breast cancer	0.00116	0.00116	CcSEcCtD
Clavulanate—Vomiting—Thiotepa—breast cancer	0.00116	0.00116	CcSEcCtD
Clavulanate—Leukopenia—Capecitabine—breast cancer	0.00116	0.00116	CcSEcCtD
Clavulanate—Convulsion—Docetaxel—breast cancer	0.00116	0.00116	CcSEcCtD
Clavulanate—Rash—Thiotepa—breast cancer	0.00115	0.00115	CcSEcCtD
Clavulanate—Dermatitis—Thiotepa—breast cancer	0.00115	0.00115	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Epirubicin—breast cancer	0.00114	0.00114	CcSEcCtD
Clavulanate—Nausea—Vinorelbine—breast cancer	0.00113	0.00113	CcSEcCtD
Clavulanate—Hypersensitivity—Fluorouracil—breast cancer	0.00111	0.00111	CcSEcCtD
Clavulanate—Haemoglobin—Methotrexate—breast cancer	0.00111	0.00111	CcSEcCtD
Clavulanate—Haemorrhage—Methotrexate—breast cancer	0.0011	0.0011	CcSEcCtD
Clavulanate—Hepatitis—Methotrexate—breast cancer	0.0011	0.0011	CcSEcCtD
Clavulanate—Pain—Paclitaxel—breast cancer	0.0011	0.0011	CcSEcCtD
Clavulanate—Anaphylactic shock—Docetaxel—breast cancer	0.00109	0.00109	CcSEcCtD
Clavulanate—Pruritus—Gemcitabine—breast cancer	0.00109	0.00109	CcSEcCtD
Clavulanate—Nausea—Thiotepa—breast cancer	0.00108	0.00108	CcSEcCtD
Clavulanate—Diarrhoea—Mitoxantrone—breast cancer	0.00108	0.00108	CcSEcCtD
Clavulanate—Diarrhoea—Irinotecan—breast cancer	0.00108	0.00108	CcSEcCtD
Clavulanate—Pruritus—Fluorouracil—breast cancer	0.00107	0.00107	CcSEcCtD
Clavulanate—Thrombocytopenia—Docetaxel—breast cancer	0.00107	0.00107	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Doxorubicin—breast cancer	0.00106	0.00106	CcSEcCtD
Clavulanate—Diarrhoea—Gemcitabine—breast cancer	0.00105	0.00105	CcSEcCtD
Clavulanate—Erythema multiforme—Methotrexate—breast cancer	0.00104	0.00104	CcSEcCtD
Clavulanate—Haemoglobin—Epirubicin—breast cancer	0.00104	0.00104	CcSEcCtD
Clavulanate—Haemorrhage—Epirubicin—breast cancer	0.00103	0.00103	CcSEcCtD
Clavulanate—Hepatitis—Epirubicin—breast cancer	0.00103	0.00103	CcSEcCtD
Clavulanate—Diarrhoea—Fluorouracil—breast cancer	0.00103	0.00103	CcSEcCtD
Clavulanate—Thrombocytopenia—Capecitabine—breast cancer	0.00103	0.00103	CcSEcCtD
Clavulanate—Urticaria—Paclitaxel—breast cancer	0.00102	0.00102	CcSEcCtD
Clavulanate—Vomiting—Irinotecan—breast cancer	0.001	0.001	CcSEcCtD
Clavulanate—Vomiting—Mitoxantrone—breast cancer	0.001	0.001	CcSEcCtD
Clavulanate—Rash—Mitoxantrone—breast cancer	0.000993	0.000993	CcSEcCtD
Clavulanate—Rash—Irinotecan—breast cancer	0.000993	0.000993	CcSEcCtD
Clavulanate—Dermatitis—Mitoxantrone—breast cancer	0.000992	0.000992	CcSEcCtD
Clavulanate—Dermatitis—Irinotecan—breast cancer	0.000992	0.000992	CcSEcCtD
Clavulanate—Erythema multiforme—Epirubicin—breast cancer	0.000978	0.000978	CcSEcCtD
Clavulanate—Vomiting—Gemcitabine—breast cancer	0.000976	0.000976	CcSEcCtD
Clavulanate—Rash—Gemcitabine—breast cancer	0.000968	0.000968	CcSEcCtD
Clavulanate—Dermatitis—Gemcitabine—breast cancer	0.000967	0.000967	CcSEcCtD
Clavulanate—Haemoglobin—Doxorubicin—breast cancer	0.000962	0.000962	CcSEcCtD
Clavulanate—Vomiting—Fluorouracil—breast cancer	0.000959	0.000959	CcSEcCtD
Clavulanate—Haemorrhage—Doxorubicin—breast cancer	0.000957	0.000957	CcSEcCtD
Clavulanate—Hepatitis—Doxorubicin—breast cancer	0.000957	0.000957	CcSEcCtD
Clavulanate—Rash—Fluorouracil—breast cancer	0.000951	0.000951	CcSEcCtD
Clavulanate—Dermatitis—Fluorouracil—breast cancer	0.000951	0.000951	CcSEcCtD
Clavulanate—Hypersensitivity—Paclitaxel—breast cancer	0.000947	0.000947	CcSEcCtD
Clavulanate—Nausea—Irinotecan—breast cancer	0.000936	0.000936	CcSEcCtD
Clavulanate—Nausea—Mitoxantrone—breast cancer	0.000936	0.000936	CcSEcCtD
Clavulanate—Pain—Docetaxel—breast cancer	0.000931	0.000931	CcSEcCtD
Clavulanate—Nausea—Gemcitabine—breast cancer	0.000912	0.000912	CcSEcCtD
Clavulanate—Pruritus—Paclitaxel—breast cancer	0.000909	0.000909	CcSEcCtD
Clavulanate—Erythema multiforme—Doxorubicin—breast cancer	0.000905	0.000905	CcSEcCtD
Clavulanate—Pain—Capecitabine—breast cancer	0.000902	0.000902	CcSEcCtD
Clavulanate—Nausea—Fluorouracil—breast cancer	0.000896	0.000896	CcSEcCtD
Clavulanate—Diarrhoea—Paclitaxel—breast cancer	0.000879	0.000879	CcSEcCtD
Clavulanate—Leukopenia—Methotrexate—breast cancer	0.000861	0.000861	CcSEcCtD
Clavulanate—Urticaria—Capecitabine—breast cancer	0.000838	0.000838	CcSEcCtD
Clavulanate—Convulsion—Methotrexate—breast cancer	0.000833	0.000833	CcSEcCtD
Clavulanate—Vomiting—Paclitaxel—breast cancer	0.000817	0.000817	CcSEcCtD
Clavulanate—Rash—Paclitaxel—breast cancer	0.00081	0.00081	CcSEcCtD
Clavulanate—Dermatitis—Paclitaxel—breast cancer	0.000809	0.000809	CcSEcCtD
Clavulanate—Leukopenia—Epirubicin—breast cancer	0.000806	0.000806	CcSEcCtD
Clavulanate—Hypersensitivity—Docetaxel—breast cancer	0.000802	0.000802	CcSEcCtD
Clavulanate—Anaphylactic shock—Methotrexate—breast cancer	0.000785	0.000785	CcSEcCtD
Clavulanate—Convulsion—Epirubicin—breast cancer	0.00078	0.00078	CcSEcCtD
Clavulanate—Hypersensitivity—Capecitabine—breast cancer	0.000777	0.000777	CcSEcCtD
Clavulanate—Pruritus—Docetaxel—breast cancer	0.000771	0.000771	CcSEcCtD
Clavulanate—Thrombocytopenia—Methotrexate—breast cancer	0.000769	0.000769	CcSEcCtD
Clavulanate—Nausea—Paclitaxel—breast cancer	0.000763	0.000763	CcSEcCtD
Clavulanate—Pruritus—Capecitabine—breast cancer	0.000746	0.000746	CcSEcCtD
Clavulanate—Leukopenia—Doxorubicin—breast cancer	0.000745	0.000745	CcSEcCtD
Clavulanate—Diarrhoea—Docetaxel—breast cancer	0.000745	0.000745	CcSEcCtD
Clavulanate—Anaphylactic shock—Epirubicin—breast cancer	0.000735	0.000735	CcSEcCtD
Clavulanate—Convulsion—Doxorubicin—breast cancer	0.000722	0.000722	CcSEcCtD
Clavulanate—Diarrhoea—Capecitabine—breast cancer	0.000721	0.000721	CcSEcCtD
Clavulanate—Thrombocytopenia—Epirubicin—breast cancer	0.000719	0.000719	CcSEcCtD
Clavulanate—Vomiting—Docetaxel—breast cancer	0.000692	0.000692	CcSEcCtD
Clavulanate—Rash—Docetaxel—breast cancer	0.000687	0.000687	CcSEcCtD
Clavulanate—Dermatitis—Docetaxel—breast cancer	0.000686	0.000686	CcSEcCtD
Clavulanate—Anaphylactic shock—Doxorubicin—breast cancer	0.00068	0.00068	CcSEcCtD
Clavulanate—Pain—Methotrexate—breast cancer	0.000671	0.000671	CcSEcCtD
Clavulanate—Vomiting—Capecitabine—breast cancer	0.00067	0.00067	CcSEcCtD
Clavulanate—Thrombocytopenia—Doxorubicin—breast cancer	0.000665	0.000665	CcSEcCtD
Clavulanate—Rash—Capecitabine—breast cancer	0.000665	0.000665	CcSEcCtD
Clavulanate—Dermatitis—Capecitabine—breast cancer	0.000664	0.000664	CcSEcCtD
Clavulanate—Nausea—Docetaxel—breast cancer	0.000647	0.000647	CcSEcCtD
Clavulanate—Pain—Epirubicin—breast cancer	0.000628	0.000628	CcSEcCtD
Clavulanate—Nausea—Capecitabine—breast cancer	0.000626	0.000626	CcSEcCtD
Clavulanate—Urticaria—Methotrexate—breast cancer	0.000624	0.000624	CcSEcCtD
Clavulanate—Urticaria—Epirubicin—breast cancer	0.000584	0.000584	CcSEcCtD
Clavulanate—Pain—Doxorubicin—breast cancer	0.000581	0.000581	CcSEcCtD
Clavulanate—Hypersensitivity—Methotrexate—breast cancer	0.000578	0.000578	CcSEcCtD
Clavulanate—Pruritus—Methotrexate—breast cancer	0.000555	0.000555	CcSEcCtD
Clavulanate—Hypersensitivity—Epirubicin—breast cancer	0.000541	0.000541	CcSEcCtD
Clavulanate—Urticaria—Doxorubicin—breast cancer	0.00054	0.00054	CcSEcCtD
Clavulanate—Diarrhoea—Methotrexate—breast cancer	0.000537	0.000537	CcSEcCtD
Clavulanate—Pruritus—Epirubicin—breast cancer	0.00052	0.00052	CcSEcCtD
Clavulanate—Diarrhoea—Epirubicin—breast cancer	0.000503	0.000503	CcSEcCtD
Clavulanate—Hypersensitivity—Doxorubicin—breast cancer	0.000501	0.000501	CcSEcCtD
Clavulanate—Vomiting—Methotrexate—breast cancer	0.000499	0.000499	CcSEcCtD
Clavulanate—Rash—Methotrexate—breast cancer	0.000495	0.000495	CcSEcCtD
Clavulanate—Dermatitis—Methotrexate—breast cancer	0.000494	0.000494	CcSEcCtD
Clavulanate—Pruritus—Doxorubicin—breast cancer	0.000481	0.000481	CcSEcCtD
Clavulanate—Vomiting—Epirubicin—breast cancer	0.000467	0.000467	CcSEcCtD
Clavulanate—Nausea—Methotrexate—breast cancer	0.000466	0.000466	CcSEcCtD
Clavulanate—Diarrhoea—Doxorubicin—breast cancer	0.000465	0.000465	CcSEcCtD
Clavulanate—Rash—Epirubicin—breast cancer	0.000463	0.000463	CcSEcCtD
Clavulanate—Dermatitis—Epirubicin—breast cancer	0.000463	0.000463	CcSEcCtD
Clavulanate—Nausea—Epirubicin—breast cancer	0.000436	0.000436	CcSEcCtD
Clavulanate—Vomiting—Doxorubicin—breast cancer	0.000432	0.000432	CcSEcCtD
Clavulanate—Rash—Doxorubicin—breast cancer	0.000429	0.000429	CcSEcCtD
Clavulanate—Dermatitis—Doxorubicin—breast cancer	0.000428	0.000428	CcSEcCtD
Clavulanate—Nausea—Doxorubicin—breast cancer	0.000404	0.000404	CcSEcCtD
